Real-World Assessment of VEVYE® for Short-Term Symptom and Sign Improvement of Dry Eye Disease in a Neuro-Ophthalmology Clinic: A 6-Month Prospective Observational Study

Part of paid clinical trials in Houston, Texas.

Sponsor
Neuro-Ophthalmology of Texas
Study ID
NCT07566975
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Cyclosporine ophthalmic solution 0.1% — OTHER
    one drop in both eyes twice a day

Study Details

patients from a Neuro Ophthalmology who have dry eye, some of which have neurotrophic keratitis are being analyzed after treatment with Vevye

Key Dates

Start date
Mar 31, 2026
Status verified
Apr 2026
Primary completion
Nov 30, 2026
Completion
Nov 30, 2026

Study Design

Enrollment
50 participants (estimated)

Arms

  • Arm: Dry Eye without neurotrophic changes
  • Arm: Dry Eye with neurotrophic changes

Primary Outcome Measure

Corneal fluorescein staining [ Time Frame: Baseline compared to week 4 ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Neuro Ophthalmology of TXHoustonTexas77074
Laura Perez
[email protected]
2817238593
Rosa A Tang, MD
[email protected]
7132580009

Find similar trials in Houston, TX

By research site
Neuro Ophthalmology of TX· Houston, TX

Related Studies